Send us an emailKyowa Hakko
COMPANY DETAILS
Am Wehrhahn 50
40211 Düsseldorf
Germany
+49 211 175 450
HEALTH CATEGORIES
Kyowa Hakko offers a line of well-researched, branded ingredients and an extensive portfolio of quality-assured, ultra-pure amino acids, paraprobiotics, vitamins, nucleic acids and related compounds for use in pharmaceutical and nutritional applications.
Manufactured exclusively by KYOWA HAKKO BIO CO., LTD., a global specialty fermentation company, Kyowa’s branded ingredients are backed by 60 years of research and innovation to deliver targeted, condition-specific consumer health benefits.
Our core business areas:
- Pharmaceuticals
- Supplements & Nutrition
Pharmaceuticals
Pharmaceutical companies around the world purchase our high-quality Active Pharmaceutical Ingredients and excipients that can be used in a wide variety of pharmaceutical applications.
Supplement & Nutrition
Kyowa is committed to ongoing scientific research, quality management and consumer education for its products. Kyowa’s branded ingredients have been designed to deliver targeted, condition-specific consumer health benefits and are backed by science.
Our ingredients bear the Kyowa Quality mark, which means that all products are manufactured to meet highest quality assurance standards, supplying quality and trusted materials for various industries such as pharmaceuticals, foods, and cosmetics.
Key branded ingredients include:
IMMUSE®, Lactococcus lactis strain Plasma
IMMUSE®, is the ?rst paraprobiotic ingredient clinically researched to directly activate pDC (plasmacytoid dendritic cells), a rare subset of immune cells, providing comprehensive innate and adaptive immune support. Backed by 26 studies, including 11 human trials, add IMMUSE®, to your next product.
Setria® Glutathione
Known as ‘The Master Antioxidant’, Setria® Glutathione is a tripeptide composed of L-Glutamic acid, L-Cysteine and Glycine. Setria® helps protect cells from the damaging effects of toxins and oxidative stress and plays a key role in supporting immune function.
Setria® Performance Blend
Setria® Performance Blend is a clinically researched blend of glutathione and made in the USA L-Citrulline that may support nitric oxide production. New research in resistance-trained males suggests that Setria® Performance Blend may help sustain NO levels which could lead to reduced fatigue and speed post-workout recovery.
Cognizin® Citicoline
Cognizin® Citicoline is a proprietary brain-health nutrient that has been clinically shown to support mental energy, focus, attention and recall. Cognizin® is approved as Novel Food Ingredient in the European Union and can be added to food supplements and food for special medical purposes.
VELOX™ Patented Performance Blend
VELOX™ Blend is a clinically studied blend of two made in the USA amino acids—L-Citrulline and L-Arginine— that has been shown to boost Nitric Oxide levels more rapidly than L-Arginine alone. Help your customers achieve their personal best with VELOX™ Patented Performance Blend .
NUTRITION & HEALTH NEWS
05 May 2023 --- This week in nutrition news, FrieslandCampina Ingredients has secured approval for its Biotis galacto-oligosaccharides (GOS) to be used in gut health supplements in Australia.... Read More
BUSINESS NEWS
10 Feb 2023 --- This week in nutrition news, Royal DSM received regulatory approval for its human milk oligosaccharide (HMO) 3-fucosyllactose (3-FL) ingredient in the US and Australia. Kyowa Hakko... Read More
NUTRITION & HEALTH NEWS
19 Sep 2022 --- As industry adjusts to a myriad of developments ranging from consumer demands to a vastly changing regulatory landscape, companies are eyeing opportunities across the APAC region.... Read More
NUTRITION & HEALTH NEWS
12 Aug 2022 --- Kyowa Hakko USA is launching the “Tap Challenge Game” app, enabling e-gamers to see the effects of the company’s citicoline supplement, Cognizin, on their finger... Read More
NUTRITION & HEALTH NEWS
27 Jul 2022 --- Postbiotics are seeing increasing interest in targeting a healthy gut microbiome for infants, according to Stratum Nutrition. Though prebiotics and probiotics are proliferating the... Read More
26 Jan 2021 --- In light of the increasing global demand for HMOs, Kyowa Hakko Bio is eyeing opportunities within the Chinese and Thai markets, despite a hazy regulatory environment. Moreover, the company is investing in a new Thai facility to expand its production capacity. Kentaro Yanashima, Research & Business Development for Kyowa Hakko Bio, tells NutritionInsight all about the promising potential of HMO’s for both infant and adult nutrition and the company’s expansion plans.
17 Oct 2022 --- IMMUSE® Lactococcus lactis strain Plasma is a unique, patent-protected, heat-killed lactic acid bacteria strain, more commonly referred to as a postbiotic, with a novel mechanism of action that stimulates immune function at the cellular level.This Technical Paper is from Kyowa Hakko.
26 Jul 2021 --- This week’s NewsBite podcast details how COVID-19 has had a major impact on consumer habits around supplementation, with NPD tackling everything from weight management to immunity. Additionally, Kappa Bioscience investigated the link between COVID-19 outcomes and levels of vitamins D and K2.
